244 related articles for article (PubMed ID: 18952105)
41. Containing pandemic influenza at the source.
Longini IM; Nizam A; Xu S; Ungchusak K; Hanshaoworakul W; Cummings DA; Halloran ME
Science; 2005 Aug; 309(5737):1083-7. PubMed ID: 16079251
[TBL] [Abstract][Full Text] [Related]
42. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Chawla R; Sharma RK; Bhardwaj JR
Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
[TBL] [Abstract][Full Text] [Related]
43. Modelling the evolution of drug resistance in the presence of antiviral drugs.
Wu J; Yan P; Archibald C
BMC Public Health; 2007 Oct; 7():300. PubMed ID: 17953775
[TBL] [Abstract][Full Text] [Related]
44. Antivirals and the control of influenza outbreaks.
Hota S; McGeer A
Clin Infect Dis; 2007 Nov; 45(10):1362-8. PubMed ID: 17968836
[TBL] [Abstract][Full Text] [Related]
45. Peptide inhibitors against influenza virus.
Rajik M; Yusoff K
Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
[TBL] [Abstract][Full Text] [Related]
46. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
47. Influenza viruses resistant to neuraminidase inhibitors.
Nitsch-Osuch A; Brydak LB
Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
[TBL] [Abstract][Full Text] [Related]
48. Vaccines and antiviral drugs in pandemic preparedness.
Monto AS
Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
[TBL] [Abstract][Full Text] [Related]
49. Detection and control of influenza outbreaks in well-vaccinated nursing home populations.
Monto AS; Rotthoff J; Teich E; Herlocher ML; Truscon R; Yen HL; Elias S; Ohmit SE
Clin Infect Dis; 2004 Aug; 39(4):459-64. PubMed ID: 15356805
[TBL] [Abstract][Full Text] [Related]
50. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
51. [Role of antiviral drugs in containing pandemic influenza. Contribution of recent modelling exercises synthesis prepared by the InVS/Inserm "epidemiology" group - November 2005].
Lévy-Bruhl D
Med Mal Infect; 2006 Sep; 36(9):449-53. PubMed ID: 17027218
[TBL] [Abstract][Full Text] [Related]
52. Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model.
Towers S; Vogt Geisse K; Zheng Y; Feng Z
J Theor Biol; 2011 Nov; 289():259-68. PubMed ID: 21867715
[TBL] [Abstract][Full Text] [Related]
53. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
Parker R; Loewen N; Skowronski D
Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
[TBL] [Abstract][Full Text] [Related]
54. Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern?
Ansaldi F; Valle L; Amicizia D; Banfi F; Pastorino B; Sticchi L; Icardi G; Gasparini R; Crovari P
J Prev Med Hyg; 2006 Mar; 47(1):1-3. PubMed ID: 17061402
[No Abstract] [Full Text] [Related]
55. Use of antiviral agents and other measures in an influenza pandemic.
Groeneveld K; van der Noordaa J
Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380
[TBL] [Abstract][Full Text] [Related]
56. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
[TBL] [Abstract][Full Text] [Related]
57. Antivirals--current trends in fighting influenza.
Król E; Rychłowska M; Szewczyk B
Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
[TBL] [Abstract][Full Text] [Related]
58. The potential for multidrug-resistant influenza.
van der Vries E; Schutten M; Boucher CA
Curr Opin Infect Dis; 2011 Dec; 24(6):599-604. PubMed ID: 22001947
[TBL] [Abstract][Full Text] [Related]
59. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics.
Carrat F; Luong J; Lao H; Sallé AV; Lajaunie C; Wackernagel H
BMC Med; 2006 Oct; 4():26. PubMed ID: 17059593
[TBL] [Abstract][Full Text] [Related]
60. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
Lackenby A; Democratis J; Siqueira MM; Zambon MC
Antivir Ther; 2008; 13(6):809-20. PubMed ID: 18839782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
